168 related articles for article (PubMed ID: 25135996)
1. Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
Atkins CD
J Clin Oncol; 2014 Oct; 32(29):3341. PubMed ID: 25135996
[No Abstract] [Full Text] [Related]
2. Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.
Chan A; Chiang J; Lew KY; Chay WY
J Clin Oncol; 2011 Jun; 29(16):e489; author reply e490-1. PubMed ID: 21482983
[No Abstract] [Full Text] [Related]
3. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
Grothey A; Nikcevich DA; Sloan JA; Kugler JW; Silberstein PT; Dentchev T; Wender DB; Novotny PJ; Chitaley U; Alberts SR; Loprinzi CL
J Clin Oncol; 2011 Feb; 29(4):421-7. PubMed ID: 21189381
[TBL] [Abstract][Full Text] [Related]
4. Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
Loprinzi CL; Qin R; Dakhil SR; Fehrenbacher L; Flynn KA; Atherton P; Seisler D; Qamar R; Lewis GC; Grothey A
J Clin Oncol; 2014 Apr; 32(10):997-1005. PubMed ID: 24297951
[TBL] [Abstract][Full Text] [Related]
5. Calcium/magnesium infusion for oxaliplatin-induced neuropathy: protective or not?
Avan A; Avan A; Giovannetti E; Peters GJ
J Clin Oncol; 2014 Oct; 32(29):3341. PubMed ID: 25135990
[No Abstract] [Full Text] [Related]
6. [Assessment of the protective effect of calcium-magnesium infusion and glutathione on oxaliplatin-induced neurotoxicity].
Dong M; Xing PY; Liu P; Feng FY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):208-11. PubMed ID: 20450590
[TBL] [Abstract][Full Text] [Related]
7. Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy.
Chay WY; Tan SH; Lo YL; Ong SY; Ng HC; Gao F; Koo WH; Choo SP
Asia Pac J Clin Oncol; 2010 Dec; 6(4):270-7. PubMed ID: 21114776
[TBL] [Abstract][Full Text] [Related]
8. Reply to C.d. Atkins and a. Avan et Al.
Loprinzi CL; Qin R; Grothey A
J Clin Oncol; 2014 Oct; 32(29):3342-3. PubMed ID: 25135995
[No Abstract] [Full Text] [Related]
9. Calcium and magnesium for oxaliplatin-induced neuropathy.
Stansfield L
Am J Health Syst Pharm; 2014 Jun; 71(12):987-8. PubMed ID: 24865753
[No Abstract] [Full Text] [Related]
10. [Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].
Muto O; Ando H; Ono T; Itagaki H; Kobayashi Y; Onuki M; Akashi T; Tanaka Y; Hanaoka T
Gan To Kagaku Ryoho; 2007 Apr; 34(4):579-81. PubMed ID: 17431344
[TBL] [Abstract][Full Text] [Related]
11. Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?
Cavaletti G
Oncologist; 2011; 16(12):1667-8. PubMed ID: 22128117
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?
Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC
J Clin Oncol; 2011 Jun; 29(18):e553-4; author reply e555-6. PubMed ID: 21606425
[No Abstract] [Full Text] [Related]
13. Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?
Khattak MA
Oncologist; 2011; 16(12):1780-3. PubMed ID: 22128115
[TBL] [Abstract][Full Text] [Related]
14. Peripheral sensory neuropathy--fighting cold with cold.
Castro M
Lancet Oncol; 2008 May; 9(5):415-6. PubMed ID: 18452855
[No Abstract] [Full Text] [Related]
15. Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate.
Wrzesinski SH; McGurk ML; Donovan CT; Ferencz TM; Saif MW
Anticancer Drugs; 2007 Jul; 18(6):721-4. PubMed ID: 17762403
[TBL] [Abstract][Full Text] [Related]
16. Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice.
Pachman DR; Ruddy K; Sangaralingham LR; Grothey A; Shah ND; Beutler AS; Hubbard JM; Loprinzi CL
J Natl Compr Canc Netw; 2015 Sep; 13(9):1097-101. PubMed ID: 26358793
[TBL] [Abstract][Full Text] [Related]
17. Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).
Pachman DR; Qin R; Seisler DK; Smith EM; Beutler AS; Ta LE; Lafky JM; Wagner-Johnston ND; Ruddy KJ; Dakhil S; Staff NP; Grothey A; Loprinzi CL
J Clin Oncol; 2015 Oct; 33(30):3416-22. PubMed ID: 26282635
[TBL] [Abstract][Full Text] [Related]
18. New data question treatment for oxaliplatin neurotoxicity.
Wolf SL
Clin J Oncol Nurs; 2008 Feb; 12(1):14; author reply 14. PubMed ID: 18323035
[No Abstract] [Full Text] [Related]
19. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
Chang YY; Lin JK; Jiang JK
Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
[No Abstract] [Full Text] [Related]
20. The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients.
Knijn N; Tol J; Koopman M; Werter MJ; Imholz AL; Valster FA; Mol L; Vincent AD; Teerenstra S; Punt CJ
Eur J Cancer; 2011 Feb; 47(3):369-74. PubMed ID: 21067912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
